BMY

Bristol-Myers Squibb Company (BMY)

Last Price$59.810.5%
Market Cap$97.6B
LTM Revenue
$47.4B
YoY Growth
+5.6%
3Y CAGR
+1.4%
5Y CAGR
+14.4%
Stock quality & Intrinsic value
7/10
13.3% overvalued

Bristol-Myers Squibb Company Revenue

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
$19.4B
$19.2B
$17.9B
$19.3B
$20.6B
$18.8B
$19.5B
$21.2B
$17.6B
$16.4B
$15.9B
$16.6B
$19.4B
$20.8B
$22.6B
$26.1B
$42.5B
$46.4B
$46.2B
$45.0B
See the BMY
full fundamental analysis
View -->
Overvalued or undervalued?
Check the intrinsic value for BMY
Explore -->

Bristol-Myers Squibb Company (BMY) Revenue comparison analysis

Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Bristol-Myers Squibb Company's Revenue?

As of today, Bristol-Myers Squibb Company's last 12-month Revenue is $47.4B, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is Bristol-Myers Squibb Company's Revenue growth rate?

Over the last year, Bristol-Myers Squibb Company's Revenue growth was 5.6%. The average annual Revenue growth rates for Bristol-Myers Squibb Company have been 3.5% over the past three years, 14.4% over the past five years.

3) Is Bristol-Myers Squibb Company's Revenue growth rate Good?

Over the last year, Bristol-Myers Squibb Company's Revenue growth was 5.6%, which is higher than industry growth of 0.1%. It indicates that Bristol-Myers Squibb Company's Revenue growth is Good.

4) How does Bristol-Myers Squibb Company's Revenue growth rate compare to its peers?

Over the last year, Bristol-Myers Squibb Company's Revenue growth was 5.6%, which is higher than peer median growth of 4.1%. The list of peers includes JNJ, SNY, MRK, PFE, ABBV, NVS, AZN, LLY, AMGN, GILD etc.